Appili Therapeutics Inc

Appili Therapeutics Inc

APLIF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$132.37K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Appili Therapeutics IncAppili Therapeutics Inc0-25%--0.7

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$132,366.00
Enterprise Value$13.32 Million
Earnings per Share$-0.03
Beta-0.21
Outstanding Shares132,366,120

Return

Return on Equity24.61%ROE
Return on Assets-361.50%
Return on Invested Capital31.88%

Valuation & Multiples

P/E Ratio-P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue35.16
Enterprise Value to EBIT-2.27
Enterprise Value to Net Income-3
Total Debt to Enterprise1
Debt to Equity-0.7Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS
-$0.01
Est. -$0.04
Revenue
$15,755
Est. $15,755

Next Earnings Call

Expected Date
February 11, 2027
EPS Estimate
-$0.05
Consensus analyst estimate
Revenue Estimate
$16,099
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Appili Therapeutics Inc

7 employees
CEO: Don Cilla

Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective progr...